유전자 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Genetic Testing Market size is expected to reach USD 122.83 Billion in 2034 from USD 19.08 Billion (2025) growing at a CAGR of 22.99% during 2026-2034.

The global genetic testing market is witnessing strong growth due to the increasing demand for personalized medicine and early disease detection. Genetic testing analyzes DNA to identify inherited conditions, genetic mutations, and potential health risks. These tests are widely used for diagnosing genetic disorders, cancer risk assessment, prenatal screening, and ancestry testing.

Advances in genomic technologies, particularly next-generation sequencing, have significantly improved the speed and accuracy of genetic testing. Healthcare providers are increasingly using genetic data to develop targeted treatment plans and predict disease susceptibility. The growing awareness of preventive healthcare and expanding access to genetic testing services are also contributing to market expansion.

In the future, the genetic testing market is expected to grow rapidly as precision medicine becomes more widely adopted. Increased investments in genomic research and declining sequencing costs will make genetic testing more accessible. As healthcare systems focus more on personalized treatments, genetic testing will become an essential component of modern medicine.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Next Generation Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Others

By Application

• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness

By Product

• Consumables
• Equipment
• Software & Services

By Channel

• Online
• Offline

By End Use

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• 24Genetics, Circle DNA, Tellmegen, 23andMe, AncestryDNA, MyDNA, Everly Well, Igenomix, VitaGen, Myriad Genetics Inc, Mapmygenome, Helix OpCo LLC, MyHeritage Ltd, Illumina Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Array Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. PCR-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. FISH Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ancestry & Ethnicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Traits Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genetic Disease Carrier Status Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TESTING MARKET: BY NEW BABY SCREENING 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast New Baby Screening
• 6.2. Health and Wellness Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Product
• 7.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TESTING MARKET: BY CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Channel
• 8.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENETIC TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End Use
• 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENETIC TESTING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Technology
  • 10.2.2 By Application
  • 10.2.3 By New Baby Screening
  • 10.2.4 By Product
  • 10.2.5 By Channel
  • 10.2.6 By End Use
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Technology
  • 10.3.2 By Application
  • 10.3.3 By New Baby Screening
  • 10.3.4 By Product
  • 10.3.5 By Channel
  • 10.3.6 By End Use
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Technology
  • 10.4.2 By Application
  • 10.4.3 By New Baby Screening
  • 10.4.4 By Product
  • 10.4.5 By Channel
  • 10.4.6 By End Use
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Technology
  • 10.5.2 By Application
  • 10.5.3 By New Baby Screening
  • 10.5.4 By Product
  • 10.5.5 By Channel
  • 10.5.6 By End Use
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Technology
  • 10.6.2 By Application
  • 10.6.3 By New Baby Screening
  • 10.6.4 By Product
  • 10.6.5 By Channel
  • 10.6.6 By End Use
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENETIC TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 24Genetics
  • 12.2.2 Circle DNA
  • 12.2.3 Tellmegen
  • 12.2.4 23andMe
  • 12.2.5 AncestryDNA
  • 12.2.6 MyDNA
  • 12.2.7 Everly Well
  • 12.2.8 Igenomix
  • 12.2.9 VitaGen
  • 12.2.10 Myriad Genetics Inc
  • 12.2.11 Mapmygenome
  • 12.2.12 Helix OpCo LLC
  • 12.2.13 MyHeritage Ltd
  • 12.2.14 Illumina Inc